During the past decade, SC Cardiomed SRL, Iasi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SC Cardiomed SRL, Iasi" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SC Cardiomed SRL, Iasi" are "Atrial Fibrillation" (2 trials), "Heart Failure" (1 trials), "Myocardial Infarction" (1 trials), "Prevention of Stroke or Systemic Embolism" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "SC Cardiomed SRL, Iasi" in a lesser frequency.

Most popular intervention types in "SC Cardiomed SRL, Iasi" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "SC Cardiomed SRL, Iasi" are 4 trials for "All" genders.

Currently, there are NaN active trials in "SC Cardiomed SRL, Iasi". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SC Cardiomed SRL, Iasi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SC Cardiomed SRL, Iasi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".